Ainos (AIMD) investor relations material

Ainos Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Q3 2025 earnings summary13 Nov, 2025

Executive summary

  • Accelerated commercialization of AI-powered scent digitization (AI Nose), with pilot deployments, six industrial partnerships, and a $2.1 million subscription order for 1,400 units from ASE Technology Holding Co.

  • Strategic focus on scaling AI Nose for 2026, expanding pilots, and strong visibility at major industrial exhibitions.

  • Transitioned industry classification to Technology Hardware, Storage & Peripherals, reflecting a shift from biotech to digital olfaction.

  • VELDONA pipeline advancing clinical trials in Taiwan for HIV-related oral warts and Sjögren's syndrome, with Orphan Drug Designation from the FDA for the HIV indication.

  • Revenue growth driven by VELDONA pet supplement sales and VOC sensing products; COVID-19 test kits discontinued.

Financial highlights

  • Q3 2025 revenue was $2,167, up from nil in Q3 2024; nine-month revenue reached $113,037, up from $20,729 year-over-year.

  • Q3 2025 net loss was $2,931,702, a 21% improvement from $3,699,317 in Q3 2024; nine-month net loss was $10,302,714, up 1% from $10,209,149 year-over-year.

  • Gross profit for Q3 2025 was $1,690, compared to a gross loss of $547 in Q3 2024; nine-month gross profit was $93,390, versus a loss of $31,945 in the prior year.

  • Operating expenses for Q3 2025 were $2,785,883, down 8% year-over-year; SG&A expenses declined 22% and R&D expenses slightly decreased.

  • Cash and cash equivalents as of September 30, 2025, were $1,128,217, down from $3,892,919 at year-end 2024.

Outlook and guidance

  • Positioned for 2026 commercial scale-up, leveraging a growing partner ecosystem and expanding SmellTech-as-a-Service model.

  • Continued investment in product development, clinical trials, and commercialization of AI Nose and VELDONA platforms.

  • Management expects ongoing net losses and negative operating cash flows for at least the next twelve months; substantial doubt exists about the ability to continue as a going concern without additional funding.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Ainos earnings date

Q4 20256 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Ainos earnings date

Q4 20256 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Ainos Inc. is a healthcare technology company focused on the development of medical diagnostic solutions and therapeutics. The company specializes in point-of-care testing devices and therapeutic innovations based on its proprietary technologies. Ainos’ product offerings include rapid diagnostic tests for infectious diseases and other health conditions, aiming to provide efficient and accessible healthcare solutions. The company also explores advancements in other areas, such as AI-driven diagnostics and anti-inflammatory treatments. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage